Restoration of normoxia by ozone therapy may control neoplastic growth: A review and a working hypothtesis

Journal of Alternative and Complementary Medicine

Volumn 11, Issue 2, 2005, Pages 257-265

  Bocci, Velio ^a   Larini, Alessandra ^a   Micheli, Vanna ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; OZONE;

ANGIOGENESIS; BLOOD TRANSFUSION; CANCER CONTROL; CANCER GROWTH; FATIGUE; HUMAN; HYPOXIA; ISCHEMIA; METASTASIS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN THERAPY; OXYGENATION; OZONATED AUTOHEMOTHERAPY; OZONE THERAPY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW;

CELL HYPOXIA; HUMANS; NEOPLASMS; OXYGEN; OXYGEN CONSUMPTION; OZONE;

EID: 18444397498     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2005.11.257     Document Type: Review

References (105)

1. Bak I, Papp G, Turoczi T, Varga E, Szendrei L, Vecsernyes M, Joo F, Tosaki A. The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med 2002;33:639-648.
2. Barber E, Menéndez S, León OS, Barber MO, Merino N, Calunga JL, Cruz E, Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediat Inflamm 1999;8:37-41.
3. Bergo GW, Tyssebotn I. Cardiovascular effects of hyperbaric oxygen with and without addition of carbon dioxide. Eur J Appl Physiol Occup Physiol 1999;80:264-275.
4. Bergofsky EH, Bertun P. Response of regional circulations to hyperoxia. J Appl Physiol 1966;21:567-572.
5. Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, Antognoni P, Dahl O, Richaud P, van Glabbeke M. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the cooperative group of radiotherapy of the European organization for research and treatment of cancer (EORTC). Radiother Oncol 2000;55:111-119.
6. Biedunkiewicz B, Tylicki L, Nieweglowski T, Burakowski S, Rutkowski B. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: An oxygen-controlled study. Int J Artif Organs 2004;27:29-34.
7. Bocci V. Roles of interferon produced in physiological conditions. A speculative review. Immunology 1988;64:1-9.
8. Bocci V. Does ozone therapy normalize the cellular redox balance? Med Hypotheses 1996a;46:150-154.
9. Bocci V. Ozone as a bioregulator: Pharmacology and toxicology of ozonetherapy today. J Biol Regulat Homeost Agent 1996b;10:31-53.
10. Bocci V. Ozonetherapy as a possible biological response modifier in cancer. Forsch Komplementärmed 1998;5:54-60.
11. Bocci V. Ozone as Janus: This controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3-11.
12. Bocci V. Biological and clinical effects of ozone. Has ozonetherapy a future in medicine? Brit J Biomed Sci 1999;56:270-279.
13. Bocci V. Oxygen-ozone therapy: A critical evaluation. Dordrecht, Netherlands: Kluwer Academic Publishers, 2002.
14. Bocci V. Ozone: A New Medical Drug. Dordrecht, The Netherlands: Springer, 2005:132-144.
15. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Rossi R, Cardaioli E, Di Simplicio P. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res 1993a;12:121-126.
16. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J Biol Regulat Homeost Agent 1993b;7:133-138.
17. Bocci V, Luzzi E, Corradeschi F, Paulesu L. Studies on the biological effects of ozone: 5. Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapy. Biotherapy 1994;7:83-90.
18. Bocci V, Paulesu L. Studies on the biological effects of ozone: 1. Induction of interferon gamma on human leucocytes. Haematologica 1990;75:510-515.
19. Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regulat Homeost Agent 1998a;12:67-75.
20. Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm 1998b;7:313-317.
21. Bocci V, Valacchi G, Rossi R, Giustarini D, Paccagnini E, Pucci AM, Di Simplicio P. Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 1999;10:110-116.
22. Brahimi-Horn C, Berra E, Pouyssegur J. Hypoxia: The tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol 2001;11:S32-S36.
23. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-943.
24. Brown JM. The hypoxic cell: A target for selective cancer therapy (18th Bruce F. Cain Memorial Award lecture). Cancer Res 1999;59:5863-5870.
25. Burkey KO, Eason G. Ozone tolerance in snap bean is associated with elevated ascorbic acid in the leaf apoplast. Physiol Plant 2002;114:387-394.
26. Bush RS, Jenkin RD, Allt WE Beale FA, Bean H, Dembo AJ, Pringle JF. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl 1978;37:302-306.
27. Calabrese EJ. Hormesis: Changing view of the dose-response, a personal account of the history and current status. Mutat Res 2002;511:181-189.
28. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E. Role of HIF-1-alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-490.
29. Clavo B, Perez JL, Lopez L, Suarez G, Lloret M, Rodriguez V, Macias D, Santana M, Morera J, Fiuza D, Robaina F, Gunderoth M. Effect of ozone therapy on muscle oxygenation. J Altern Complement Med 2003;9:251-256.
30. Clavo B, Perez JL, Lopez L, Suarez G, Lloret M, Rodriguez V, Macias D, Santana M, Hernandez MA, Martin-Oliva R, Robaina F. Ozone therapy for tumor oxygenation: A pilot study. Evid Based Complement Altern Med 2004a;1:93-98.
31. Clavo B, Ruiz A, Lloret M, Lopez L, Suarez G, Macias D, Rodriguez V, Hernandez MA, Martin-Oliva R, Quintero S, Cuyas JM, Robaina F. Adiuvant ozonetherapy in advanced head and neck tumors: A comparative study. Evid Based Complement Alternat Med 2004b;1:321-325.
32. Coleman CN. Hypoxia in tumors: A paradigm for the approach to biochemical and physiologic heterogeneity. J Natl Cancer Inst 1988;80:310-317.
33. Cross CE, Motchnik PA, Bruener BA, Jones DA, Kaur H, Ames BN, Halliwell B. Oxidative damage to plasma constituents by ozone. FEBS Lett 1992;298:269-272.
34. De Maio A. Heat shock proteins: Facts, thoughts, and dreams. Shock 1999;11:1-12.
35. Denko NC, Giaccia AJ. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res 2001;61:795-798.
36. Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977;123:463-474.
37. Dische S, Anderson PJ, Sealy R, Watson ER. Carcinoma of the cervix: Anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 1983;56:251-255.
38. Dore S. Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer's disease. Free Radic Biol Med 2002;32:1276-1282.
39. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001;7:693-698.
40. Dvorak HF. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 2003;162:1747-1757.
41. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
42. Falk SJ, Ward R, Bleehen NM. The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised pO2 histography. Br J Cancer 1992;66:919-924.
43. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002;20:680-687.
44. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14:831-838.
45. Giunta R, Coppola A, Luongo C, Sammartino A, Guastafierro S, Grassia A, Giunta L, Mascolo L, Tirelli A, Coppola L. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol 2001;80:745-748.
46. Goldman M. Cancer risk of low-level exposure. Science 1996;271:1821-1822.
47. Griffin RJ, Okajima K, Barrios B, Song CW. Mild temperature hyperthermia combined with carbogen breathing increases tumor partial pressure of oxygen (pO2) and radiosensitivity. Cancer Res 1996;56:5590-5593.
48. Gutstein HB. The biologic basis of fatigue. Cancer 2001;92:1678-1683.
49. Harris AL. Hypoxia: A key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
50. Helczynska K, Kronblad A, Jogi A, Nilsson E, Beckman S, Landberg G, Pahlman S. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003;63:1441-1444.
51. Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 1995;19:115-119.
52. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515.
53. Hockel M, Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-276.
54. Honess DJ, Andrews MS, Ward R, Bleehen NM. Pentoxifylline increases RIF-1 tumour pO2 in a manner compatible with its ability to increase relative tumour perfusion. Acta Oncol 1995;34:385-389.
55. Horsman MR, Chaplin DJ, Brown JM. Tumor radiosensitization by nicotinamide: A result of improved perfusion and oxygenation. Radiat Res 1989;118:139-150.
56. Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 2003;278:19575-19578.
57. Imray CH, Walsh S, Clarke T, Tiivas C, Hoar H, Harvey TC, Chan CW, Forster PJ, Bradwell AR, Wright AD, Birmingham Medical Research Expeditionary Society. Effects of breathing air containing 3% carbon dioxide, 35% oxygen or a mixture of 3% carbon dioxide/35% oxygen on cerebral and peripheral oxygenation at 150 m and 3459 m. Clin Sci 2003;104:203-210.
58. Inch WR, McCredie JA, Sutherland RM. Effect of duration of breathing 95 percent oxygen plus 5 percent carbon dioxide before x-irradiation on cure of C3H mammary tumor. Cancer 1970;25:926-931.
59. Jacobs M-T. Side-effects and typical complication due to ozonetherapy [in German]. OzoNachrichten 1982;1:5.
60. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitroso-haemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996;380:221-226.
61. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000;92:1564-1572.
62. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, Yagi T, Nakagami M, Takada Y, Morimoto T, Yamaoka Y. Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996;128:251-258.
63. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002;8:240-246.
64. León OS, Menéndez S, Merino N, Castillo R, Sam S, Perez L, Cruz E, Bocci V. Ozone oxidative preconditioning: A protection against cellular damage by free radicals. Mediators Inflamm 1998;7:289-294.
65. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B, Epoetin Alpha Study Group. Effects of epoetin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-2874.
66. Marrades RM, Roca J, Campistol JM, Diaz O, Barbera JA, Torregrosa JV, Masclans JR, Cobos A, Rodriguez-Roisin R, Wagner PD. Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. J Clin Invest 1996;97:2092-2100.
67. Mattassi R, D'Angelo F, Bisetti P, Colombo R, Vaghi M. Parenteral ozonetherapy in peripheral obstructive arteriopathies: Biochemical mechanism and clinical results [in Italian]. Il Giornale Di Chirurgia 1987;8:109-111.
68. Micheli V, Ricci C, Taddeo A, Gili R. Centrifugal fractionation of human erythrocytes according to age: Comparison between Ficoll and Percoll density gradients. Quad Sclavo Diagn 1985;21:236-248.
69. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995;96:2676-2682.
70. Overgaard J, Gonzalez GD, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995;345:540-543.
71. Paulesu L, Luzzi E, Bocci V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-α) on human leucocytes. Lymphokine Cytokine Res 1991;10:409-412.
72. Rokitansky O, Rokitansky A, Steiner J, Trubel W, Viebahn R, Washüttl J. Ozonetherapy in peripheral arteriopathies: Clinic, biochemist and gas-analysis determinations [in German]. In: Water. Berlin: Ozon-Weltkongress, 1981:53-75.
73. Romero Valdes A, Menendez Cepero S, Gomez Moraleda M, Gomez Moraleda M, Ley Pozo J. Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologia 1993;45:146-148.
74. Rubin P, Hanley J, Keys HM, Marcial V, Brady L. Carbogen breathing during radiation therapy: The Radiation Therapy Oncology Group Study. Int J Radiat Oncol Biol Phys 1979;5:1963-1970.
75. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-3015.
76. Semenza GL. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 2003;54:17-28.
77. Semenza GL. Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001;7:345-350.
78. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.
79. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer 2002;38:27-43.
80. Sharma YK, Leon J, Raskin I, Davis KR. Ozone-induced responses in Arabidopsis thaliana: The role of salicylic acid in the accumulation of defense-related transcripts and induced resistance. Proc Natl Acad Sci U S A 1996;93:5099-5104.
81. Shinriki N, Suzuki T, Takama K, Fukunaga K, Ohgiya S, Kubota K, Miura T. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologia 1998;29:229-239.
82. Siemann DW, Hill RP, Bush RS. The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma. Int J Radiat Oncol Biol Phys 1977;2:903-911.
83. Siemann DW, Horsman MR, Chaplin DJ. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing. Radiother Oncol 1994;31:117-122.
84. Snyder SH, Baranano DE. Heme oxygenase: A font of multiple messengers. Neuropsychopharmacology 2001;25:294-298.
85. Song CW, Hasegawa T, Kwon HC, Yang DH, Cho BH, Lee ST. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. Radiat Res 1992;130:205-210.
86. Song CW, Lee I, Hasegawa T, Rhee JG, Levitt SH. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. Cancer Res 1987;47:442-446.
87. Song CW, Shakil A, Griffin RJ, Okajima K. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen. Semin Oncol 1997;24:626-632.
88. Song CW, Shakil A, Osborn JL, Iwata K. Tumor oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia, 1996;12:367-373.
89. Stone JR, Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 2002;9:231-238.
90. Subarsky P, Hill RP. The hypoxic tumor microenvironment and metastatic progression. Clin Exp Metastasis 2003;20:237-250.
91. Sweet F, Kao M-S, Lee S-CD, Hagar WL, Sweet WE. Ozone selectively inhibits growth of human cancer cells. Science 1980;209:931-933.
92. Teicher BA, Rose CM. Perfluorochemical emulsions can increase tumor radiosensitivity. Science 1984;223:934-936.
93. Thomson AJ, Webb DJ, Maxwell SR, Grant IS. Oxygen therapy in acute medical care. BMJ 2002;324:1406-1407.
94. Tosetti F, Ferrari N, De Flora S, Albini A. Angioprevention: Angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 2002;16:2-14.
95. Tylicki L, Niewglowski T, Biedunkiewicz B, Burakowski S, Rutkowski B. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs: Pilot study. Int J Artif Organs 2001;24:79-82.
96. Tylicki L, Nieweglowski T, Biedunkiewicz B, Chamienia A, Debska-Slizien A, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs. Int J Artif Organs 2003;26:297-303.
97. Tylicki L, Biedunkiewicz B, Nieweglowski T, Chamienia A, Slizien AD, Luty J, Lysiak-Szydlowska W, Rutkowski B. Ozonated autohemotherapy in patients on maintenance hemodialysis: Influence on lipid profile and endothelium. Artif Organs 2004;28:234-237.
98. Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm 1999;8:205-209.
99. Valacchi G, Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediators Inflamm 2000;9:271-276.
100. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994;28:163-169.
101. Vaupel P, Hockel M. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance. Int J Oncol 2000;17:869-879.
102. Wolff HH. Ozone in Medicine: Theoretical Basis and Therapeutic Advantages [in German]. Heidelberg, Verlag für Medizin, 1979.
103. Young SD, Marshall RS, Hill RP. Hypoxia induces DNA over-replication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 1988;85:9533-9537.
104. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59:5830-5835.
105. Zuckerbraun BS, Billiar TR. Heme oxygenase-1: A cellular Hercules. Hepatology 2003;37:742-744.